Mindfulness therapy for picky eaters? study halted early
NCT ID NCT06110806
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new therapy that combines mindfulness and exposure to body sensations for teens with avoidant/restrictive food intake disorder (ARFID), where eating is very limited. The goal was to see if the therapy was acceptable and could increase the number of foods eaten. The study was stopped early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
12 people
The number who actually took part.
- Started
-
Oct 2023
- Finished
-
Jul 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patient: * Aged 12-18 * Speaks English * Permission from pediatrician or equivalent to receive outpatient care, including that the patient does not meet criteria for hospitalization based on the American Psychiatric Association guidelines * Diagnosis of Avoidant Restrictive Food Intake Disorder, as assessed by the EDA-5 Parent: * Has a child aged 12-18 with a diagnosis of ARFID * Speaks English Exclusion Criteria: * Comorbid psychotic or bipolar disorder * Psychiatric medication initiated or with a dosage change in the two weeks prior to baseline testing * Active suicidal ideation * Major medical condition (e.g., diabetes mellitus, pregnancy) * Current substance dependence, as evidenced by tolerance and withdrawal * Evidence of anatomical findings by imaging (e.g., swallow study) that would prevent safe consumption of the shake or those with a percutaneous endoscopic gastrostomy or other similar feeding tube insertion * Children with visual or physical limitations that would preclude watching a screen and using a finger to respond with mouse clicks (e.g., blindness, epilepsy if exposure to flashing lights at certain intensities or to certain visual patterns can trigger seizures).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Avoidant restrictive food intake disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Psychiatry, Eating and Weight Disorders Program
New York, New York, 10029, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could the gut microbiome hold clues to eating disorder recovery?
- 20,000-Person DNA hunt aims to crack eating disorder code
- Art and education: a new way to treat eating disorders?
- Could a common allergy drug help picky eaters gain weight?
- Family therapy shows promise for kids with eating disorder ARFID
- Can therapy help you eat again when your stomach hurts?